Preclinical studies implicated the insertion of the IL-2 gene into retroviral and adenoviral vectors, and also, a pioneer study investigated the application of a retroviral vector for the delivery of IL-2 gene vector in order to cure a fibrosarcoma animal model. This evidence concerns the gene IL2 and fibrosarcoma.